Neostigmin PANPHARMA

Medicinal product

(Invented) name

Neostigmin PANPHARMA

Active substance (s)

Neostigmino metilsulfatas

Strength

0,5 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07AA01, Neostigmine

Marketing authorisation holder

UAB Adeofarma, Lietuva

Date of authorisation

2023-07-13

Date of renewal

Documents

1938_Neostigmin PANPHARMA_2023-07-13.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ampulėje (1 ml tirpalo) yra	1 ml
Neostigmino metilsulfatas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111294	97407	1097407	ampulė	1 ml N10	ASPĮ	Receptinis	LT/L/23/1938/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-07-13	Registruotas